ArticleInternational journal of nanomedicine2026

Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment.

Antonino Di Lorenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.